Risk of ovarian cancer in women with symptoms in primary care: population based case-control study

I feel that this research is Long overdue as Ovarian Cancer has been
classed as a "silent killer" for many years, when in fact there are subtle
symptoms which can often be overlooked, (not everyone has a palpable mass
or intermenstrual bleeding to trigger an urgent referral). I welcome the
awareness this will create for both healthcare professionals and patients
alike.
Furthermore it might be prudent when female patients attend with ongoing
symptoms such as bloating/distention pain etc to carry out a CA125-11
test(improved version test introduced in 1996)at a suitable time during
the menstrual cycle for those premenstrual patients, which may help as
part of a primary care assessment/screen, although this is not readily
available in primary care at present. It is usually used as a monitoring
tool for those undergoing treatment for Ovarian CA, moreover there are
known anomalies, but many of these coupled with other ongoing symtoms
would trigger further investigation anyway and might aid in the earlier
detection of Ovarian Cancer.
In contrast a range of symptoms linked to benign causes in males does
actually trigger a PSA test for Prostate Cancer in primary care.

Competing interests:
Ovarian Cancer survivor diagnosed at age 34 years with subtle symptoms and an excellent GP.